• Flash Briefings & Podcasts

  First Patient Dosed In a Phase 2b Study With Inhaled RVT-1601 for IPF Cough

  Posted by Pulmonary Fibrosis News Moderator on August 12, 2019 at 10:40 am

  

  Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses the first patient dosed in a Phase 2b study testing inhaled RVT-1601 for IPF cough.

  What do you think of this news?

  Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/

  Pulmonary Fibrosis News Moderator replied 4 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply